# KalVista Pharmaceuticals Presents New Data Highlighting High Patient Satisfaction and Evolving Treatment Trends with EKTERLY® (sebetralstat)
Canonical URL: https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-presents-new-data-highlighting-high-patient-satisfaction-and-evolving-treatment-trends-with-ekterlyr-sebetralstat
Ticker: KALV
Company: KalVista Pharmaceuticals, Inc.
Source: KalVista Pharmaceuticals, Inc.
Published: 2026-03-02 12:00 EST
Original Source URL: https://ir.kalvista.com
## Summary

Presentations highlight patient preference for sebetralstat, early treatment as the strongest driver of response, and sustained effectiveness with use in clinical trials FRAMINGHAM, Mass. & SALISBURY, England --(BUSINESS WIRE)--Mar. 2, 2026-- KalVista Pharmaceuticals, Inc.

## Article Body
Presentations highlight patient preference for sebetralstat, early treatment as the strongest driver of response, and sustained effectiveness with use in clinical trials FRAMINGHAM, Mass. & SALISBURY, England --(BUSINESS WIRE)--Mar. 2, 2026-- KalVista Pharmaceuticals, Inc.
## Recent Company News
- 2026-05-28 11:00 EST — [KalVista Pharmaceuticals Presents New Data Highlighting the Burden of Injectable On-Demand Treatment in Young Children with Hereditary Angioedema](https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-presents-new-data-highlighting-the-burden-of-injectable-on-demand-treatment-in-young-children-with-hereditary-angioedema) — Source: KalVista Pharmaceuticals, Inc.
- 2026-04-29 11:00 EST — [Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio](https://biopharmsignal.com/news/KALV/chiesi-group-to-acquire-kalvista-pharmaceuticals-expanding-its-global-rare-disease-portfolio) — Source: KalVista Pharmaceuticals, Inc.
- 2026-04-08 11:00 EST — [KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference](https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-to-present-at-the-25th-annual-needham-virtual-healthcare-conference) — Source: KalVista Pharmaceuticals, Inc.
- 2026-04-02 20:01 EST — [KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4) — Source: KalVista Pharmaceuticals, Inc.
- 2026-03-30 11:00 EST — [KalVista Pharmaceuticals Announces Positive Interim Phase 3 Data From KONFIDENT-KID Trial of EKTERLY® (sebetralstat) for Children Aged 2-11 Years at the 2026 Global Angioedema Leadership Conference](https://biopharmsignal.com/news/KALV/kalvista-pharmaceuticals-announces-positive-interim-phase-3-data-from-konfident-kid-trial-of-ekterlyr-sebetralstat-for-children-aged-2-11-years-at-the-2026-global-angioedema-leadership-conference) — Source: KalVista Pharmaceuticals, Inc.
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)